Eva Harth
Last active: 2/15/2016


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Matrices for combined delivery of proteins and synthetic molecules. Gilmore KA, Lampley MW, Boyer C, Harth E (2016) Adv Drug Deliv Rev : 77-85
    › Primary publication · 26656604 (PubMed)
  2. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges. Lockhart JN, Stevens DM, Beezer DB, Kravitz A, Harth E (2015) J Control Release 220(Pt B): 751-7
    › Primary publication · 26344396 (PubMed)
  3. Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure. Lambert WS, Carlson BJ, van der Ende AE, Shih G, Dobish JN, Calkins DJ, Harth E (2015) Transl Vis Sci Technol 4(1): 1
    › Primary publication · 25599009 (PubMed) · PMC4294067 (PubMed Central)
  4. A new paradigm for treatment of glaucoma. Galloway RL, Delisi M, Harth EM, Mawn LA (2014) Annu Int Conf IEEE Eng Med Biol Soc : 6147-50
    › Primary publication · 25571400 (PubMed)
  5. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice. de la Croix Ndong J, Stevens DM, Vignaux G, Uppuganti S, Perrien DS, Yang X, Nyman JS, Harth E, Elefteriou F (2015) J Bone Miner Res 30(1): 55-63
    › Primary publication · 25043591 (PubMed) · PMC4280331 (PubMed Central)
  6. Nanosponge formation from organocatalytically-synthesized poly(carbonate) copoplymers. Stevens DM, Tempelaar S, Dove AP, Harth E (2012) ACS Macro Lett 1(7): 915-918
    › Primary publication · 24724044 (PubMed) · PMC3979553 (PubMed Central)
  7. Stretchable gas barrier achieved with partially hydrogen-bonded multilayer nanocoating. Holder KM, Spears BR, Huff ME, Priolo MA, Harth E, Grunlan JC (2014) Macromol Rapid Commun 35(10): 960-4
    › Primary publication · 24700525 (PubMed)
  8. Water-soluble Semiconducting Nanoparticles for Imaging. Adkins CT, Dobish JN, Brown S, Harth E (2013) ACS Macro Lett 2(8): 710-714
    › Primary publication · 24516779 (PubMed) · PMC3917510 (PubMed Central)
  9. Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked "nanosponge" network for lung cancer chemotherapy. Hariri G, Edwards AD, Merrill TB, Greenbaum JM, van der Ende AE, Harth E (2014) Mol Pharm 11(1): 265-75
    › Primary publication · 24215299 (PubMed)
  10. Intracellular neutralization of a virus using a cell-penetrating molecular transporter. Sapparapu G, Sims AL, Aiyegbo MS, Shaikh FY, Harth EM, Crowe JE (2014) Nanomedicine (Lond) 9(11): 1613-24
    › Primary publication · 24195674 (PubMed)
  11. Trans-meningeal drug delivery to optic nerve ganglion cell axons using a nanoparticle drug delivery system. Grove K, Dobish J, Harth E, Ingram MC, Galloway RL, Mawn LA (2014) Exp Eye Res : 42-5
    › Primary publication · 24184721 (PubMed)
  12. Controlled branching of polyglycidol and formation of protein-glycidol bioconjugates via a graft-from approach with "PEG-like" arms. Spears BR, Waksal J, McQuade C, Lanier L, Harth E (2013) Chem Commun (Camb) 49(24): 2394-6
    › Primary publication · 23370543 (PubMed)
  13. Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cells. Novitskiy SV, Csiki I, Huang Y, Johnson DH, Harth EM, Carbone DP, Dikov MM (2010) J Thorac Oncol 5(9): 1410-5
    › Primary publication · 20683208 (PubMed)
  14. Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors. Passarella RJ, Spratt DE, van der Ende AE, Phillips JG, Wu H, Sathiyakumar V, Zhou L, Hallahan DE, Harth E, Diaz R (2010) Cancer Res 70(11): 4550-9
    › Primary publication · 20484031 (PubMed) · PMC2880200 (PubMed Central)
  15. Effective delivery of IgG-antibodies into infected cells via dendritic molecular transporter conjugate IgGMT. Hamilton SK, Ikizler MR, Wallen C, Wright PF, Harth E (2008) Mol Biosyst 4(12): 1209-11
    › Primary publication · 19396384 (PubMed)
  16. Molecular dendritic transporter nanoparticle vectors provide efficient intracellular delivery of peptides. Hamilton SK, Harth E (2009) ACS Nano 3(2): 402-10
    › Primary publication · 19236078 (PubMed)
  17. Approach to formation of multifunctional polyester particles in controlled nanoscopic dimensions. van der Ende AE, Kravitz EJ, Harth E (2008) J Am Chem Soc 130(27): 8706-13
    › Primary publication · 18543915 (PubMed)
  18. Controlled electrophoretic deposition of uniquely nanostructured star polymer films. Somarajan S, Hasan SA, Adkins CT, Harth E, Dickerson JH (2008) J Phys Chem B 112(1): 23-8
    › Primary publication · 18069811 (PubMed)
  19. Dendritic molecular transporters provide control of delivery to intracellular compartments. Huang K, Voss B, Kumar D, Hamm HE, Harth E (2007) Bioconjug Chem 18(2): 403-9
    › Primary publication · 17284011 (PubMed)
  20. Synthesis of amino acid-based polymers via atom transfer radical polymerization in aqueous media at ambient temperature. Chung ID, Britt P, Xie D, Harth E, Mays J (2005) Chem Commun (Camb) (8): 1046-8
    › Primary publication · 15719111 (PubMed)
  21. A facile approach to architecturally defined nanoparticles via intramolecular chain collapse. Harth E, Van Horn B, Lee VY, Germack DS, Gonzales CP, Miller RD, Hawker CJ (2002) J Am Chem Soc 124(29): 8653-60
    › Primary publication · 12121107 (PubMed)
  22. The effect of macromolecular architecture in nanomaterials: a comparison of site isolation in porphyrin core dendrimers and their isomeric linear analogues. Harth EM, Hecht S, Helms B, Malmstrom EE, Fr├ęchet JM, Hawker CJ (2002) J Am Chem Soc 124(15): 3926-38
    › Primary publication · 11942830 (PubMed)
  23. New polymer synthesis by nitroxide mediated living radical polymerizations. Hawker CJ, Bosman AW, Harth E (2001) Chem Rev 101(12): 3661-88
    › Primary publication · 11740918 (PubMed)